Close
  Indian J Med Microbiol
 

Figure 3: Histopathological studies of (a) normal rat liver, (b) CCl4-treated rat liver, (c) CBD (100 mg/kg)-treated rat liver, (d) CBD (200 mg/kg)-treated rat liver, (e) EABD (100 mg/kg)-treated rat liver, (f) EABD (200 mg/kg)-treated rat liver, (g) silymarin

Figure 3: <i>Histopathological studies of (a) normal rat liver, (b) CCl<sub>4</sub>-treated rat liver, (c) CBD (100 mg/kg)</i>-<i>treated rat liver, (d) CBD (200 mg/kg)</i>-<i>treated rat liver, (e) EABD (100 mg/kg)</i>-<i>treated rat liver, (f) EABD (200 mg/kg)</i>-<i>treated rat liver, (g) silymarin</i>